Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor
2022 · EBioMedicine · 41 citations
https://doi.org/10.1016/j.ebiom.2022.103872
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
267
Citations
5
h-index
5
i10-index
Tengrui Zhang is an academic researcher from Peking University. The author has contributed to research in topics: Epigenetics and DNA Methylation & Cancer, Hypoxia, and Metabolism & RNA modifications and cancer. The author has an h-index of 5, co-authored 6 publications.
https://doi.org/10.1016/j.ebiom.2022.103872
https://doi.org/10.1016/j.phrs.2025.107922
Click to start Chat